Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2015, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2015-04-17
DOI
10.1155/2015/435713
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Artesunate Ameliorates Functional Limitations in Freund’s Complete Adjuvant-Induced Monoarthritis in Rat by Maintaining Oxidative Homeostasis and Inhibiting COX-2 Expression
- (2014) B. Guruprasad et al. INFLAMMATION
- Artesunate Abolishes Germinal Center B Cells and Inhibits Autoimmune Arthritis
- (2014) Lifei Hou et al. PLoS One
- Anti-Malarial Drug Artesunate Inhibits Primary Human Cultured Airway Smooth Muscle Cell Proliferation
- (2013) Sheryl S L Tan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell
- (2013) Xin Li et al. PLoS One
- Qinghaosu (artemisinin): Chemistry and pharmacology
- (2012) Ying Li ACTA PHARMACOLOGICA SINICA
- Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models
- (2012) C. Cheng et al. ALLERGY
- Dihydroartemisinin Ameliorates Inflammatory Disease by Its Reciprocal Effects on Th and Regulatory T Cell Function via Modulating the Mammalian Target of Rapamycin Pathway
- (2012) Yan G. Zhao et al. JOURNAL OF IMMUNOLOGY
- SM934 Treated Lupus-Prone NZB×NZW F1 Mice by Enhancing Macrophage Interleukin-10 Production and Suppressing Pathogenic T Cell Development
- (2012) Li-Fei Hou et al. PLoS One
- Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses
- (2011) Li-Fei Hou et al. ARTHRITIS AND RHEUMATISM
- Anti-Malarial Drug Artesunate Attenuates Experimental Allergic Asthma via Inhibition of the Phosphoinositide 3-Kinase/Akt Pathway
- (2011) Chang Cheng et al. PLoS One
- SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-κB pathways in RAW 264.7 macrophages
- (2009) Jun-xia Wang et al. ACTA PHARMACOLOGICA SINICA
- SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo
- (2009) Li-Fei Hou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses
- (2009) Shokoofe Noori et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1α in human rheumatoid arthritis fibroblast-like synoviocyte
- (2009) Ya He et al. RHEUMATOLOGY INTERNATIONAL
- The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses
- (2008) J-X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
- (2008) Chris J. Hedegaard et al. IMMUNOLOGY
- Artemisinin can inhibit the calmodulin-mediated activation of phosphodiesterase in comparison with Cyclosporin A
- (2008) S. Noori et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Qinghaosu (Artemisinin): The Price of Success
- (2008) N. J. White SCIENCE
- Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation
- (2007) J-X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More